The board of administrators of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has appointed Dr. Tal Zaks to serve on the board. The appointment comes into impact as of October 1, 2021 till the subsequent annual basic shareholders assembly in 2022.
Zaks is stepping down as chief medical officer of vaccine developer and producer Moderna Inc. (Nasdaq: MRNA) after six years within the place and can proceed to function a particular advisor to Moderna CEO till the tip of September. Zaks’ wage on the Teva board can be an identical to the salaries of the opposite impartial administrators on the board of the Israeli pharmaceutical firm, as declared to the US SEC on April 20, 2020.
The Teva board determined that Zaks was match to serve on the board as an impartial director in line with its guidelines of registration filed with the New York Inventory Trade. He was additionally appointed to the board’s science and expertise committee and could also be appointed to extra committees sooner or later. Zaks is a graduate of Ben Gurion College of the Negev.
Revealed by Globes, Israel enterprise information – en.globes.co.il – on August 27, 2021
Copyright of Globes Writer Itonut (1983) Ltd. 2021